Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Netflix
NFLX
|
+$385M |
| 2 |
Microsoft
MSFT
|
+$368M |
| 3 |
Berkshire Hathaway Class A
BRK.A
|
+$298M |
| 4 |
Delta Air Lines
DAL
|
+$208M |
| 5 |
Carnival Corporation Ltd
CCL
|
+$203M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$1.34B |
| 2 |
Tesla
TSLA
|
+$353M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$303M |
| 4 |
NVIDIA
NVDA
|
+$290M |
| 5 |
Boeing
BA
|
+$286M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.37% |
| 2 | Healthcare | 18.47% |
| 3 | Consumer Discretionary | 12.41% |
| 4 | Consumer Staples | 10.13% |
| 5 | Industrials | 9.95% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
GTH
3201
DELISTED
Genetron Holdings Limited ADS
GTH
| $124K | ﹤0.01% |
50,700
-133
| -0.3% | -$361 |
|
3202
Alset
AEI
$43.6M
| $123K | ﹤0.01% |
92,966
-100
| -0.1% | -$152 |
|
|
TMQ
3203
Trilogy Metals
TMQ
$653M
| $123K | ﹤0.01% |
251,500
-65,800
| -21% | -$33.5K |
|
3204
Tonix Pharmaceuticals
TNXP
$214M
| $122K | ﹤0.01% |
70
+4
| +6% | +$14.6K |
|
|
CYAN
3205
DELISTED
Cyanotech Corp
CYAN
| $122K | ﹤0.01% |
152,209
-2,300
| -1% | -$1.89K |
|
3206
Aura Biosciences
AURA
$791M
| $121K | ﹤0.01% |
13,500
-6,000
| -31% | -$64.5K |
|
3207
Celularity
CELU
$20M
| $121K | ﹤0.01% |
54,340
+26,899
| +98% | +$96.6K |
|
3208
LiveWire
LVWR
$256M
| $121K | ﹤0.01% |
+17,502
| New | +$186K |
|
3209
Skillsoft
SKIL
$78.7M
| $121K | ﹤0.01% |
6,810
+2,620
| +63% | +$66.4K |
|
|
BRAG
3210
Bragg Gaming Group
BRAG
$55.2M
| $120K | ﹤0.01% |
24,600
+8,200
| +50% | +$39.5K |
|
3211
5E Advanced Materials
FEAM
$67.3M
| $120K | ﹤0.01% |
2,300
-2,513
| -52% | -$171K |
|
|
HIVE
3212
HIVE Digital Technologies
HIVE
$706M
| $120K | ﹤0.01% |
39,020
-314,480
| -89% | -$1.34M |
|
|
ADN
3213
DELISTED
Advent Technologies
ADN
| $118K | ﹤0.01% |
10,070
-8,400
| -45% | -$165K |
|
3214
Definitive Healthcare
DH
$68.4M
| $118K | ﹤0.01% |
+14,800
| New | +$149K |
|
3215
HeartCore Enterprises
HTCR
$3.88M
| $118K | ﹤0.01% |
5,960
-418
| -7% | -$10.3K |
|
3216
Oramed Pharmaceuticals
ORMP
$178M
| $116K | ﹤0.01% |
44,300
+10,600
| +31% | +$33.4K |
|
|
HITI
3217
High Tide
HITI
$204M
| $115K | ﹤0.01% |
62,200
+38,587
| +163% | +$55.2K |
|
3218
Gray Media Inc
GTN.A
$612M
| $114K | ﹤0.01% |
15,200
+300
| +2% | +$2.68K |
|
3219
IZEA Worldwide
IZEA
$53.8M
| $114K | ﹤0.01% |
52,503
+6,478
| +14% | +$14.9K |
|
|
PVLA
3220
Palvella Therapeutics
PVLA
$2.26B
| $114K | ﹤0.01% |
4,766
+147
| +3% | +$3.16K |
|
|
FRLN
3221
DELISTED
Freeline Therapeutics Holdings plc American Depositary Shares
FRLN
| $113K | ﹤0.01% |
26,360
+4,500
| +21% | +$17.8K |
|
|
VOXR
3222
Vox Royalty Corp
VOXR
$369M
| $112K | ﹤0.01% |
55,400
+42,200
| +320% | +$94.5K |
|
|
ZEPP
3223
Zepp Health
ZEPP
$78.6M
| $112K | ﹤0.01% |
24,300
-250
| -1% | -$1.18K |
|
3224
Rani Therapeutics
RANI
$89.7M
| $111K | ﹤0.01% |
51,000
-37,201
| -42% | -$142K |
|
|
UCL
3225
uCloudlink Group
UCL
$28.6M
| $111K | ﹤0.01% |
52,405
-4,800
| -8% | -$12.4K |
|
Similar funds
Jim Simons's Q3 2023 Portfolio in Review
As of Q3 2023, Jim Simons held 4,329 positions worth $58.7B, down 15% from $69.4B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Jim Simons withdrew a net $8.34B in Q3 2023, closing 713 positions and reducing 1,794 holdings. Its most notable exit was Chevron, an estimated $185M position sold in full.
By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 20% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Jim Simons opened a new position in D.R. Horton worth $125M.
- Jim Simons's largest Q3 2023 buy was D.R. Horton: 1,159,438 shares worth $125M.
- Jim Simons added most to Netflix in Q3 2023, an estimated $385M increase.
- Jim Simons's biggest Q3 2023 reduction was Meta Platforms (Facebook), cutting an estimated $1.34B.
- Jim Simons fully exited Chevron in Q3 2023, selling an estimated $185M.
- Jim Simons's ten largest holdings make up 12% of its $58.7B portfolio in Q3 2023.
- Jim Simons opened 464 new positions and closed 713 in Q3 2023.
- Jim Simons's portfolio value fell 15% quarter-over-quarter to $58.7B.
Based on Renaissance Technologies's 13F filing for Q3 2023, filed 14 Nov 2023.